XML 30 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Significant Alliances and Related Parties (Details Textual) (USD $)
 3 Months Ended 89 Months Ended 3 Months Ended 89 Months Ended 0 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Jun. 30, 2012
Sep. 30, 2012
Thera Cour Pharma, Inc [Member]
Sep. 30, 2011
Thera Cour Pharma, Inc [Member]
Sep. 30, 2012
Thera Cour Pharma, Inc [Member]
Feb. 15, 2010
Series Preferred Stock [Member]
Sep. 30, 2012
Series Preferred Stock [Member]
Related Party Transaction, Description of Transaction charge its costs (direct and indirect) plus no more than 30% of direct costs                
Lab Supplies and Chemicals Fees $ 25,000                
Other General and Administrative Expense 2,000                
Royalty Payment Percentage Of Net Sales 15.00%                
Preferred Stock, Voting Rights four votes             four votes  
Preferred stock, shares issued               7,000,000 7,000,000
Preferred stock               7,000 7,000
Development Cost         948,026 416,679 7,565,030    
Security Deposit         386,608   386,608    
Equity Method Investment, Ownership Percentage 21.00%   21.00%   70.00%   70.00%    
Common stock, shares, outstanding 158,391,799   158,391,799 155,612,293 33,360,000   33,360,000    
Lab Fees $ 561,168 $ 0 $ 2,421,755